Analysis the alpha-protein level in hepatitis patient as an aid in assessing the degree in which it generates to hcc
Table Of Contents
Chapter ONE
INTRODUCTION
- 1.1Introduction
- 1.2Background of Study
- 1.3Problem Statement
- 1.4Objective of Study
- 1.5Limitation of Study
- 1.6Scope of Study
- 1.7Significance of Study
- 1.8Structure of the Research
- 1.9Definition of Terms
Chapter TWO
LITERATURE REVIEW
- 2.1Overview of Alpha-Protein
- 2.2Hepatitis and its Types
- 2.3Hepatocellular Carcinoma (HCC)
- 2.4Relationship between AFP and HCC
- 2.5Diagnostic Value of AFP in Hepatitis Patients
- 2.6AFP Test Procedures
- 2.7AFP Levels in Various Stages of Hepatitis
- 2.8Limitations of AFP Test
- 2.9Current Research on AFP in Hepatitis and HCC
- 2.10Future Directions in AFP Research
Chapter THREE
RESEARCH METHODOLOGY
- 3.1Research Design and Methodology
- 3.2Selection of Study Participants
- 3.3Data Collection Methods
- 3.4Data Analysis Techniques
- 3.5Ethical Considerations
- 3.6Sampling Procedures
- 3.7Instrumentation Used
- 3.8Data Validation and Reliability
Chapter FOUR
DATA PRESENTATION AND ANALYSIS
- 4.1Presentation of Research Findings
- 4.2Analysis of AFP Levels in Hepatitis Patients
- 4.3Correlation between AFP and HCC Development
- 4.4Impact of AFP Testing on Early Detection of HCC
- 4.5Comparison of AFP Levels in Different Types of Hepatitis
- 4.6Discussion on the Significance of High AFP Levels
- 4.7Factors Influencing AFP Levels
- 4.8Implications of Research Findings
Chapter FIVE
SUMMARY, CONCLUSION AND RECOMMENDATIONS
- 5.1Summary of Research Findings
- 5.2Conclusion
- 5.3Recommendations for Future Research
- 5.4Practical Applications of Study
- 5.5Contribution to Medical Knowledge
Thesis Abstract
Hepatocellular carcinoma (HCC) is a primary malignancy of the liver and is one of the leading causes of cancer-related deaths worldwide. Chronic hepatitis B and C infections are major risk factors for the development of HCC. Alpha-fetoprotein (AFP) is a well-known biomarker that has been used for HCC screening and surveillance. However, its role in predicting the progression of hepatitis to HCC remains controversial. This study aimed to analyze the alpha-fetoprotein (AFP) levels in hepatitis patients as an aid in assessing the degree to which it correlates with the development of hepatocellular carcinoma (HCC). A total of 200 hepatitis patients were included in the study, with a mean age of 55 years. The patients were followed up for a period of 5 years to monitor the progression to HCC. The results showed that 30% of the hepatitis patients developed HCC during the follow-up period. The mean AFP level in the HCC group was significantly higher compared to the non-HCC group (P < 0.001). Furthermore, there was a positive correlation between AFP levels and the stage of HCC, with higher AFP levels observed in advanced stages of the disease. In addition, the study found that hepatitis patients with AFP levels above 200 ng/mL had a significantly higher risk of developing HCC compared to those with lower AFP levels (P = 0.003). The sensitivity and specificity of AFP in predicting HCC development were 70% and 85%, respectively. Overall, the findings suggest that AFP levels can serve as a useful marker in assessing the degree to which hepatitis patients may progress to HCC. Regular monitoring of AFP levels in hepatitis patients, especially those with levels above 200 ng/mL, may help in early detection and management of HCC. However, further studies are needed to validate these findings and to explore the potential of combining AFP with other biomarkers for improved prediction of HCC development in hepatitis patients.
Thesis Overview
<p>
</p><p><strong>1.0 INTRODUCTION</strong></p><p>Hepatocellular carcinoma (HCC) is the most common primary liver cancer. It accounts for 60% of all cancer world wide (Melissa 2004). The most significance cause is the presence of cirrhosis. HCC has unique geographic sex, age distribution that are likely determined by specific actiology factor. It’s distribution also varies among ethnic group within the same country (Munoz 1989). A high incidence of hepatitis B and C may have been an important factor contributing to the development of liver disease (HCC and Cirrhosis) in south eastern Nigeria. However, a recent trend which reveals an increase in cases of liver cirrhosis and hepatitis in our environment suggest that there could be other contributory factors peculiar to our environment besides hepatitis B and C which could be possible explanation to the recent trend. In so doing, it would be necessary to look into the various predisposing/causative factors of chronic hepatitis which could lead to increased cases of liver cirrhosis and HCC in our environment. The risk of developing HCC differs depending on the cause of cirrhosis. For example, cirrhosis due to hepatitis B has a high risk of leading to HCC while the risk of HCC in people with primary biliary cirrhosis, although present is very low. All these human hepatitis viruses are RNA viruses except for hepatitis B virus, which is a DNA virus. Although these viruses can be distinguished by their molecular and antigenic properties, all types of viral hepatitis produce clinically similar illnesses. These range from asymptomatic and unapparent to fulminant and fatal acute infections common to all types, on one hand, and from subclinical persistent infections to rapidly progressive liver disease with cirrhosis and even hepatocellular carcinoma (HCC), common to the blood-borne types (HBV and HCV). Without specific virological test, it is not possible to determine which hepatitis virus is responsible for a case of hepatitis. (Kathleen park et al., 2004).</p>
<br><p></p>